Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Scholar Rock

< Previous 1 2 3 Next >
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Announces the Addition of Katie Peng to Its Board of Directors and Promotes Mo Qatanani, Ph.D. to Chief Scientific Officer
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Presents New Preclinical Data Demonstrating Potential Benefit of SRK-439 for Healthy Weight Loss Management
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Announces Presentation of New Preclinical Data Evaluating SRK-439 in Obesity at Keystone Symposia
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Announces FDA Clearance of IND Application to Initiate Phase 2 Proof-of-Concept Trial with Apitegromab to Treat Obesity
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Participate in Upcoming Investor Conferences
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Provide Business Update on November 7, 2023
From Scholar Rock
Via Business Wire
Tickers SRK
Scholar Rock to Present Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 38th Annual Meeting
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Advance Antimyostatin Program to Develop Novel Therapies for Cardiometabolic Disorders
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Announces Completion of Enrollment for the Phase 3 SAPPHIRE Trial
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports Second Quarter 2023 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Present at the Jefferies Healthcare Conference
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Present New Data Evaluating Apitegromab at 36 Months from the Phase 2 TOPAZ trial at the 2023 Annual Cure SMA Conference
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Announces the Addition of Richard Brudnick to Its Board of Directors
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports Full Year 2022 Financial Results and Highlights Business Progress
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Present 24-Month Data from the Phase 2 TOPAZ trial at the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock to Present at the Cowen 43rd Annual Health Care Conference
From Scholar Rock
Via Business Wire
Tickers SRRK
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Scholar Rock
Via Business Wire
Tickers SRRK
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.